Catalyst Wire Dossier Catalyst Wire Dossier

Cobimetinib (Cotellic)

cobimetinib · Genentech
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cobimetinib (Cotellic), covering 2017-06-23 to 2018-05-09. Get the full timeline:

Most recent: Clinical Trial Update: ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma [Phase 2]

See pricing